C-J Advisory’s Pfizer PFE Stock Holding History

C-J Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-211	Closed	-$7K	–	121
2019 Q3	$7K	Hold	211	–	–	﹤0.01%	136
2019 Q2	$9K	Hold	211	–	–	0.01%	132
2019 Q1	$9K	Buy	+211	New	+$8.45K	0.01%	146

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

C-J Advisory's PFE Position: Q4 2019 in Review

C-J Advisory sold out of Pfizer (PFE) in Q4 2019, closing a stake of 211 shares — an estimated $7K sold.

C-J Advisory first reported a position in PFE in Q1 2019 and held it in 3 quarters. The position peaked at $9K in Q2 2019. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

C-J Advisory reported no remaining Pfizer position as of Q4 2019 after selling out during the quarter.
C-J Advisory sold 211 Pfizer shares in Q4 2019, an estimated $7K.
C-J Advisory first reported a position in Pfizer in Q1 2019 and held it in 3 quarters.
C-J Advisory's Pfizer position peaked at $9K in Q2 2019.
2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on C-J Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.